Search for: "SCHERING-PLOUGH" Results 301 - 320 of 404
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
5 Mar 2013, 12:36 pm by Michelle Yeary
  737 F.Supp.2d at 922-23 (citing In re ScheringPlough Corp. [read post]
29 Aug 2012, 10:09 pm by FDABlog HPM
(“Merck”) (formerly Schering-Plough Corporation) restricted competition in violation of the Sherman Act by settling patent infringement lawsuits against potential generic K-DUR entrants, including Upsher-Smith Laboratories (“Upsher-Smith”). [read post]
25 Nov 2008, 1:55 pm
Schering Plough's $76,000 contribution to a legitimate charity -- the favorite of a senior Polish official -- resulted in a $500,000 fine in June 2004 when the company failed to account for the payment as the bribe that it was deemed to be. [read post]
30 Jul 2009, 7:02 am
The same Bloomberg article also re-caps the most recent (albeit a bit dated) information about the extent of this ongoing  Fosamax litigation: Merck, which is buying rival Schering-Plough Corp., had a reserve of about $24 million for the litigation, including lawyers' fees, as of March 31, having spent $9 million on the cases in the first quarter, the company said in May. [read post]
20 Mar 2009, 6:00 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com]   Highlights this week included: US: Reps Eshoo, Inslee and Barton introduce Pathway for Biosimilars Act (FDA Law Blog) (Patent Docs) (Patent Baristas) (Patent Baristas) (Law360) US: Reps Waxman, Pallone, Deal and Emerson introduce Promoting Innovation and Access to Life-Saving Medicine Act (Intellectual Property Watch) (IPKat) (Patent Docs) EU: Pharma submissions relating to… [read post]
26 Nov 2008, 7:19 pm
Schering-Plough, 05-273, denied June 26, 2006)  In its case against Rambus, the FTC barred that company for three years from collecting royalties on products that followed the industry standard on computer memories, to the extent those royalties went beyond what Rambus would have been able to collect if it had not used deception and had negotiated beforehand with companies that would license its technology. [read post]
23 Oct 2008, 10:18 am
Since Jeff Kindler took over as CEO of Pfizer he's kicked out pretty much everyone on the old management team and replaced them with his own ...peterrost.blogspot.com/2008/05/jeff-kindlers-new-pfizer-only-democrats.html - 75k - Cached - Similar pages - Note thisTHE PETER ROST BLOG: Jeff Kindler discovered in IndiaPfizer CEO Jeff Kindler has apparently decided to retrace the footsteps of his spies in India to ascertain if they did anything he wouldn't have done.… [read post]
22 May 2013, 6:55 pm by Dan Markel
Pasquale, Schering-Plough Professor in Health Care Regulation and Enforcement, Seton Hall University School of Law Randal C. [read post]
22 Apr 2012, 12:07 pm
Organon is part of the Schering-Plough Corporation, which is now owned by Merck. [read post]
4 Sep 2008, 9:08 pm
2008 Medical Journal Articles Describe Two Cases; Authors Suggest Liver Testing At Start Of Therapy And When Titrating Dosage Is Necessary (Posted by Tom Lamb at DrugInjuryWatch.com) In December 2007 we told you  about an article by New York Times (NYT) reporter Alex Berenson, "Data About Zetia Risks Was Not Fully Revealed", which revealed that Merck and Schering-Plough had conducted several studies of Zetia that raised the possibility that Zetia can cause… [read post]
24 May 2007, 12:49 pm
Schering-Plough, the Solicitor General urged the Court not to grant cert. to consider whether federal antitrust laws prohibit the manufacturer of a patented brand-name drug from entering into an agreement with the manufacturer of a generic substitute to share its future profits from the sale of the brand-name drug in exchange for the generic manufacturer's agreement not to market the substitute. [read post]
7 Feb 2008, 8:48 am
Cesan — former CEO of Schering-Plough; noted Levitra expert Daniel H. [read post]
4 Aug 2009, 1:15 am
Merck, which is buying rival Schering-Plough Corp., had a reserve of about $24 million for the litigation, including lawyers' fees, as of March 31, having spent $9 million on the cases in the first quarter, the company said in May. [read post]
15 Jan 2010, 10:49 am by Joshua Kubicki
This means looking at "the facts and the law and the witnesses and the documents" according to PD Villarreal, the head of litigation for Schering-Plough. [read post]
26 Nov 2007, 3:06 pm
The October 2007 FDA staff report was prepared in advance of a meeting of an advisory panel of pediatricians later this week being convened to consider the safety of Serevent and Advair (made by GlaxoSmithKline PLC), both of which contain the active ingredient salmeterol, as well as another asthma drug, Foradil (made by Novartis AG and marketed in the U.S. by Schering-Plough Corp.), which contains the active ingredient formoterol. [read post]
25 Apr 2012, 1:56 pm by Jeffrey May
The FTC’s brief urges the Third Circuit to reverse a decision of the federal district court in New Jersey granting summary judgment ((CCH) 2010-1 Trade Cases ¶76,949) in favor of the patent holder, Schering-Plough Corporation, and the alleged infringers–Upsher Smith and ESI. [read post]